[1] |
SHI Yifan, LI Bo, YU Miao, MA Yinhao, LIU Qian, HU Jing, WANG Hong, ZHANG Huina, WANG Tianyuan.
Medical Clinical Science Research in the Context of Internet Medicine
[J]. Chinese General Practice, 2025, 28(14): 1694-1701.
|
[2] |
LI Bingsong, LYU Yitong, LEI Tianchu, LIU Yuchen, ZHEN Xuemei, WANG Jian.
Research on the Integrated Development of TCM and Primary Health Care under ROCCIPI Framework
[J]. Chinese General Practice, 2025, 28(12): 1549-1552.
|
[3] |
WAN Xiaowen, HUANG Rong, MA Lirong, SHI Muran, SHENG Wenbin, ZENG Cheng, WU Ning.
Traditional Chinese Medicine Policies and Development Status in China
[J]. Chinese General Practice, 2025, 28(10): 1161-1169.
|
[4] |
ZHENG Xiaomeng, ZHOU Xuan, SUN Yu, FAN Miao, JIN Yiyi, ZHU Suyan.
Clinical Characteristics and Medication Patterns of Patients with Cardiometabolic Multimorbidity
[J]. Chinese General Practice, 2025, 28(09): 1061-1064.
|
[5] |
ZHU Suyan, ZHENG Xiaomeng, FAN Miao, CHEN Chunyan.
Interpretation of the Screening Tool of Older Person's Potentially Inappropriate Prescriptions/Screening Tool to Alert to Right Treatment (STOPP/START) Criteria (Version 3)
[J]. Chinese General Practice, 2024, 27(33): 4097-4104.
|
[6] |
ZHOU Jingjing, HE Kaiyue, LIU Ailing, ZHAO Lanhui, GAO Jing, ZHOU Shangcheng.
Impact of ICD-11 Inclusion of TCM Codes on the Global Burden of Disease
[J]. Chinese General Practice, 2024, 27(06): 746-750.
|
[7] |
XU Huijing, WU Shanyu, JIANG Jiawei, WU Yuanhong, WANG Xiaohui, GAO Ge, WANG Zhe, WANG Yuyu.
Translation of the Patient-reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life and Its Validation in Elderly Patients with Polypharmacy
[J]. Chinese General Practice, 2024, 27(05): 612-621.
|
[8] |
ZENG Senxiang, YANG Rui, DENG Xun, YANG Ruitao, YANG Xiaoyan.
Management Standards of Polypharmacy in Type 2 Diabetes Combined with Atherosclerotic Cardiovascular Diseases in the Elderly
[J]. Chinese General Practice, 2024, 27(05): 597-603.
|
[9] |
ZHENG Rong, LIU Zhidong, WANG Miao, ZHANG Xiao, CHEN Junlan, ZHOU Shigao.
A Randomized Controlled Study on Gehu Tiaozhi Decoction Intervening Patients with Metabolic Syndrome
[J]. Chinese General Practice, 2024, 27(03): 343-347.
|
[10] |
PAN Hongwei, LIU Li, MA Chao, DENG Guangpu, FANG Haoting, HUANG Shuwei, ZHU Hong.
The Current Status and Influencing Factors of Treatment Adherence to National Chronic Disease Management Services for Hypertensive Population in a Community Healthcare Center in Guangzhou
[J]. Chinese General Practice, 2024, 27(01): 59-66.
|
[11] |
ZHONG Pingping, NAN Yayun, PENG Linlin, ZHOU Yuting, CHEN Qiong.
A Bibliometrics Analysis of Polypharmacy in the Elderly from 2003 to 2022
[J]. Chinese General Practice, 2023, 26(35): 4404-4411.
|
[12] |
XIE Xuemei, GAO Jing, BAI Dingxi, LU Xianying, HE Jiali, LI Yue.
Current Status of Polypharmacy in the Elderly and Its Influencing Factors: a Meta-analysis
[J]. Chinese General Practice, 2023, 26(35): 4394-4403.
|
[13] |
XU Man, AN Zhuoling, ZHANG Yuhui, MA Zhuo.
Current Situation of Potentially Inappropriate Medication in Older Cancer Patients and Strategies to Address It
[J]. Chinese General Practice, 2023, 26(35): 4382-4387.
|
[14] |
XU Jian, DAI Fangfang, PAN Wenlei, HUANG Qian, LU Ping, WANG Jianfeng, JIA Huan, YANG Yuqi, HUANG Jiaoling.
Visual Analysis of Hotspots and Cutting-edge Trends of Community TCM Service Research in China in the Context of Healthy China
[J]. Chinese General Practice, 2023, 26(34): 4343-4350.
|
[15] |
WEI Lan, HUANG Yue, SONG Yanan, HOU Lihong, WANG Yani, PAN Dongchen, FEI Xiaolu.
Investigation on Platform for Evaluation Management and Consultation Services of Polypharmacy among Older Patients Needs of Healthcare Professionals
[J]. Chinese General Practice, 2023, 26(25): 3157-3162.
|